Literature DB >> 1617855

Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier.

J T Gilman1, P Gal.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1617855     DOI: 10.2165/00003088-199223010-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  42 in total

1.  The need for a loading dose of gentamicin in neonates.

Authors:  K L Watterberg; H W Kelly; P Angelus; C Backstrom
Journal:  Ther Drug Monit       Date:  1989       Impact factor: 3.681

2.  The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

Authors:  R D Moore; C R Smith; P S Lietman
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

3.  Clinical correlates of methylphenidate blood levels.

Authors:  C T Gualtieri; R E Hicks; K Patrick; S R Schroeder; G R Breese
Journal:  Ther Drug Monit       Date:  1984       Impact factor: 3.681

4.  Ethical boundaries of medical research in infants and children in the 80s: analysis of rejected protocols and a new solution for drug studies.

Authors:  G Koren
Journal:  Dev Pharmacol Ther       Date:  1990

5.  Learning ability and methylphenidate (Ritalin) plasma concentration in hyperkinetic children. A preliminary investigation.

Authors:  S S Kupietz; B G Winsberg; J Sverd
Journal:  J Am Acad Child Psychiatry       Date:  1982-01

6.  Fatal liver failure in 16 children with valproate therapy.

Authors:  D Scheffner; S König; I Rauterberg-Ruland; W Kochen; W J Hofmann; S Unkelbach
Journal:  Epilepsia       Date:  1988 Sep-Oct       Impact factor: 5.864

7.  An evaluation of optimal sampling strategy and adaptive study design.

Authors:  G L Drusano; A Forrest; M J Snyder; M D Reed; J L Blumer
Journal:  Clin Pharmacol Ther       Date:  1988-08       Impact factor: 6.875

8.  Transcutaneous theophylline collection in preterm infants.

Authors:  M G Murphy; C C Peck; D P Conner; K Zamani; G B Merenstein; D Rodden
Journal:  Clin Pharmacol Ther       Date:  1990-04       Impact factor: 6.875

9.  Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

Authors:  W M Gersony; G J Peckham; R C Ellison; O S Miettinen; A S Nadas
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

10.  Dosing implications of altered gentamicin disposition in patients with cystic fibrosis.

Authors:  G L Kearns; B C Hilman; J T Wilson
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

View more
  18 in total

Review 1.  Pharmacokinetic considerations in the treatment of childhood epilepsy.

Authors:  Jamie T Gilman; Michael Duchowny; Ana E Campo
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 2.  Common errors of drug administration in infants: causes and avoidance.

Authors:  B J Anderson; J F Ellis
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

3.  Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.

Authors:  Toshimi Kimura; Keisuke Sunakawa; Nobuo Matsuura; Hiroaki Kubo; Shigehiko Shimada; Kazuo Yago
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

Review 4.  Clinical pharmacokinetics of sedatives in neonates.

Authors:  E Jacqz-Aigrain; P Burtin
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

5.  Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities.

Authors:  Navjeet K Uppal; Lee L Dupuis; Christopher S Parshuram
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

6.  Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis.

Authors:  Stéphane Corvaisier; Bruno Charpiat; Cyril Mounier; Martine Wallon; Gilles Leboucher; Mounzer Al Kurdi; Jean-François Chaulet; François Peyron
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 7.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Transdermal reverse iontophoresis of valproate: a noninvasive method for therapeutic drug monitoring.

Authors:  M Begoña Delgado-Charro; Richard H Guy
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

9.  Safety monitoring of drugs receiving pediatric marketing exclusivity.

Authors:  P Brian Smith; Daniel K Benjamin; M Dianne Murphy; Rosemary Johann-Liang; Solomon Iyasu; Barbara Gould; Robert M Califf; Jennifer S Li; William Rodriguez
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

10.  The receptor occupation and plasma concentration of NKY-722, a water-soluble dihydropyridine-type calcium antagonist, in spontaneously hypertensive rats.

Authors:  S Uchida; S Yamada; T Ohkura; M Heshikiri; A Yoshimi; H Shirahase; R Kimura
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.